2. Digital Health Summit

2. Digital Health Summit

 30st September, 2021.
Budapest Music Center

Hungary’s first Digital Health conference. Digital health conference for public and private health care, digital pharma, and manufacturers of digital medical products.
 

Topics

Digital Health Market + Digital Health Venture +
Digital Health Startups + Digital Ecosystem +
Public Health Care Digital + Novartis Digital Health
Startup Competition + Roche Personalized Healthcare +
Digital Pharma + Digital Communication for medical doctors +
Responsible Telemedicine + etc.

Keynote speakers

Prof. Ildikó Horváth, MD., Ph.D.
Prof. Ildikó Horváth, MD., Ph.D.

State Secretary for Health
 

Mauricio Campos Suarez
Mauricio Campos Suarez

CEE Digital Lead
Novartis AG, Basel

Maiko Liebermann
Maiko Liebermann

Digital Health Leader in Oncology, Personalised Healthcare & Patient
Access, Roche, Basel

Madeleine Latapie
Madeleine Latapie

Corporate Affairs Lead
Biogen Digital Health, Páris
 

Mohamed Kamal
Mohamed Kamal

Chief Marketing Officer CEE, MSD
Lucerne

 

The 1st Digital Health Summit was in February 27th, 2020. We had 297 guests and 31 journalists attended. The 2nd Digital Health Summit was in September, 2021 with 420 guests full house. We sold out the available tickets. 

The Digital Health Summit brings together public and private health care, digital pharma, and manufacturers of digital medical products, venture capitalists ynd startups from around Hungary, to network, exchange ideas and to become more familiar with opportunities in Hungary. Our independent conference will become a significant event for many companies in the DH industry and is particularly important in Hungary given the explosion of business and entrepreneurship in the region.

Digital health is the convergence of digital technologies with health, healthcare, living, and society to enhance the efficiency of healthcare delivery and make medicines more personalized and precise. The discipline involves the use of information and communication technologies to help address the health problems and challenges faced by people under treatment. These technologies include both hardware and software solutions and services, including telemedicine, web-based analysis, email, mobile phones and applications, text messages, wearable devices, and clinic or remote monitoring sensors. Generally, digital health is concerned about the development of interconnected health systems to improve the use of computational technologies, smart devices, computational analysis techniques, and communication media to aid healthcare professionals and their clients manage illnesses and health risks, as well as promote health and wellbeing.

Digital health is a multi-disciplinary domain involving many stakeholders, including clinicians, researchers and scientists with a wide range of expertise in healthcare, engineering, social sciences, public health, health economics and data management.

Who attends
  • + Providers / Health Systems
  • + Payers
  • + Pharma
  • + Health Tech
  • + Platform Technology Pioneers
  • + Big Tech
  • + Investors
Why attend?
  • + INSPIRED. Our speakers are leading real business transformation, driving change across the enterprise and actioning measurable digital innovation for their businesses. Get motivated from leaders and walk away with new ideas you can implement.
  • + CHALLENGED. Rethink your current processes and business blueprints, the event speakers will challenge your way of thinking and allow you to realise that new methods may be your best way of moving forward sitting alongside your current beliefs.
  • + TRANSFORMED. The conference agenda and speakers are put together as such to reveal insights into how some of the biggest organisations are going about digital, from real business use cases to success stories and where the challenges may lie.
  • + MEET LIKE MINDED PEERS
  • + NETWORKING. It's an invaluable part of events and where real value often presents itself, meeting those who are facing the same challenges and coming together to solve similar issues. Our agendas feature numerous opportunities throughout the day to meet like minded folk from various industries and backgrounds. We have previously had extremely positive feedback from delegates who have found long lasted business relationships with those who they wouldn't normally meet from opposite industries and largely seeking out the same solutions to industry wide transformation sticking points.
     

     

Dress code

business formal

Organizers

AP Summit Now Kft. és Molnár Rita Judit egyéni vállalkozó

Social media

join us

Companies registered for the 2021 conference

4iG Nyrt., 77 Elektronika, AstraZeneca, Albacomp RI , Asseco CEMO, Anamed, Atlas Pharma, Andrékó Ferenczi Kinstellar Ügyvédi Iroda, Artisti-Med, ARWorks, Azonnali, Betegszoba.hu, Bay Zoltán Alkalmazott Kutatási Közhasznú Nonprofit, BCE, Belügyminisztérium, BENU Magyarország, Biogen Hungary, BME, BMS, Cashline Holding, Cerha Hempel, Citibank Europe plc Magyarországi Fióktelepe, CooperVision,Computerworld, Cytocast, Déli Klinika, Deloitte, Delaware Consulting Hungary, Dermus, Digitális Jólét Nonprofit, Debreceni Egyetem Klinikai Központjának Laboratóriuma, Dunaújvárosi Egyetem, Egészségügyi Technológia és Orvostechnikai Szállítók Egyesülete, Euromedic International Hungária,Euromedic Pharma, Euromedic Trading Kft, E-Med4all Europe,
Édes Gyermekünk Alapítvány, Egészségkalauz, eHealth Software Solutions, Emberi Erőforrások Minisztériuma, eVisit, Figyelő, Frontira Design, Fitpuli, FleishmanHillard Café, Generali Biztosító, GrandVision, Házipatika, Holland Királyság Nagykövetsége, HIPA Nonprofit, Hiventures, Hospitaly, Hunt&r, Innovációs és Technológiai Minisztérium, Insimu, Index.hu, Inspira Research, IQVIA, Istenhegyi Magánklinika, Jacsomedia, Johnson & Johnson, Janssen, Kinstellar, KNP LAW, Karc FM, KPLI Kelemen Kinga Ügyvédi Iroda, Lilly Hungária, Markodental Praxis, Mediaworks, MediAd, Medtronic Hungaria,  MedicalOnline, MedInnoScan, Merck, MFB Invest, Mind Klinika, MSD, Medipredict, MTI, Neumann Medical, Nemzeti Kutatási Fejlesztési és Innovációs Hivatal, Népszava, Novartis Hungária, Novartis AG, Novo Nordisk Hungária,
Omron Magyarország, Óbudai Egyetem, OKFŐ, Oncompass, Oppenheim, Országos Foglalkozás-Egészségügyi Szolgálat, Origin Consulting, Oracle Magyarország, Pécsi Tudományegyetem Gyógyszertudományok Doktori Iskola, Pearl Hungary, Phoenix Pharma, Pfizer, PulsenMore, Privát Doktor, PricewaterhouseCoopers Könyvvizsgáló, Quercus Consulting Group, Ramasoft, Richter Gedeon, Roche Magyarország, Sárhegyi Ügyvédi Iroda, Supercharge , Selek és Miller's, Semmelweis Egyetem, Schoenherr Hungary, Syreon Kutató Intézet, Solvo, Szinapszis, Széchenyi István Egyetem, Szintézis-Net, Takeda Pharma, T-DOC Service, TaylorWessing, Telvice, Tel Avivi Magyar Nagykövetség, Óbudai Egyetem, Ulyssys, Valor Capital, Világgazdaság, Vespucci Partners, Webbeteg, Zorkóczy Ügyvédi Iroda

Program

 

Concert Hall (ground floor)

07.30 - 08.15 Registration, breakfast, networking
08.15 - 08.20 Opening - Rita Molnár (DHS, founder)
08.20 - 08.40 Teleworking? Then it's telemedicine! - how the development of digital healthcare promotes preventive thinking - Tibor Somogyi (DokiAPP)
08.40 - 09.00 Hungarian telemedicine trends in 2021 during COVID - Telemedicine allows health care professionals to evaluate, diagnose and treat patients at a distance using telecommunications technology. As part of the measure related to the epidemiological situation, Decree No 157 of 29 April 2020 was published in the Magyar Közlöny. One of the most important points of the Government Decree is that the personal presence of the patient is not a condition for the provision and financing of the health care service, if the nature of the healthcare and the medical judgment allow it. The use of telemedicine due to the situation became a daily practice for both GPs and specialists in Hungary, and this trend does not reverse. We initiated a representative research by interviewing 600 doctors from 15 specializations to explore their impressions, the pros and cons of telemedicine, and how it can improve the quality of patient care. - Balázs Kertész (Szinapszis)
09.01 - 09.21 Immersive VR/AR and mobile solutions in the health sector – DO’s and DONT’s with several use casesImmersive and mobile technologies can be efficiently used in any field of any pharmaceutical companies or hospitals – if they really help the daily operation of the users and the organisation. Our lecture summarizes the practical requirements of several types of digital solutions throughout their development, introduction and daily use – presenting several good and bad examples and using our own IVFSIMPro project as a poster child Szabolcs Budaházy (ARWorks)
09.22 - 09.42 Keynote: Abundant funding to boost research, development and innovation in Hungary - In terms of innovation performance, Hungary is a moderate innovator in the EU, but we aspire to be among the leaders by the end of the decade. According to the latest data from the Hungarian Central Statistical Office, domestic expenditure on research and development has been rising for years, reaching an unprecedented HUF 702 billion in 2019, which is more than double of the 2010 expenditure. Medical sciences and health industry are traditionally outstanding in the Hungarian RDI landscape, but contributions from this sector are even more appreciated due to the coronavirus pandemic crisis. Government funding to foster research, development and innovation sees a significant increase also this year: over HUF 160 billion will be spent from national funds, while the new EU financed operational program will bring further calls worth several hundred billion HUF for the Hungarian RDI ecosystem, just in 2021 alone. - István Szabó, Phd (National Research, Development and Innovation Office)
09.43 - 10.03 Keynote: Latest news of digital health development - By the development and nationwide introduction of the National eHealth Infrastructure, Hungary is leading the way in laying the foundation of a digital healthcare system. In terms of digital public services, this infrastructure is still one of Europe’s best. In November 2017, Hungary introduced an accessible and effective digital infrastructure that provides major developments for the domestic healthcare system. Digital solutions and telemedicine both have huge potential for our future society, as the structured collection, storage and lawful utilization of healthcare data represents a significant value. Today the National eHealth Infrastructure (EESZT), operated by the National Healthcare Service Center, is an integral part of healthcare and diagnostic work and is used by physicians and patients as well. - Bálint Szabó (National Healthcare Service Center)
10.04 - 10.27 Keynote: Improving patient outcomes and personalising healthcare with digital solutions Maiko Liebermann (Digital Health Leader Oncology, Personalised Healthcare & Patient Access, Roche) (the pre-recorded presentation is in English, no rendering in other languages available)
10.28 - 10.58 Keynote: Pharma Ecosystem Innovation: Value proposition & real life experience - Top 3 highlights and learnings from running open innovation for pharma + to bring some insights/outside-in perspective from The Wide lens theory + Novartis BIOME CEE plans + what we could propose to start today to collaborate with Hungary Startups ecosystem - Mauricio Campos Suarez (Novartis AG, Basel) (the zoom presentation is in English, no rendering in other languages available)
10.59 - 11.20 Coffee break, networking
11.20 - 11.40 Digital Therapy Planning in Precision Oncology - The challenge of precision oncology is to choose which mutant gene to target with which targeted therapy to achieve response in the presence of the specific mutation and the presence of all the other mutant genes. The solution to this problem is the help of artificial intelligence. Digital therapy planning can potentially increase the efficacy and cost-efficacy of precision oncology.- István Peták, MD, PhD(Oncompass)
11.41 - 12.01 Keynote: Digital Innovation in NeuroscienceMadeleine Latapie (Biogen Digital Health, Paris) live Zoom presentation (the presentation is in English, no rendering in other languages available)
12.02 - 12.22 Keynote: Straight and honest talk: Artfical Intelligence in healthcare - The future belongs to knowledge-driven and data-intensive solutions. The big question is, how do we move from data to information extraction to greater knowledge, to international research and its exploitation for better healthcare? In this talk, we will explore our real-life experience based the challenges, limitations and opportunities of AI application in healthcare and share human-centric solutions as well. - Antal Kuthy (E-Group)
12.23 - 12.43 Understanding the endless complexity of the human body and predicting its diseases - Medipredict is a digital health company providing a comprehensive evaluation of individual  health status by combining information from multiple sources, such as detailed medical examinations,  medical imaging, microbiome analysis, metabolomics, genomics and processing medical history. Our  mission is to help people maximize their health by using cutting-edge technology and evidence-based  science to predict disease risk, provide early detection and give actionable insights to maintain optimal  health. - Richárd, Kiss, MD, PhD (Medipredict) 
12.44 - 13.04 New medical technology solutions in remote patient management - Diabetes mellitus is responsible for a huge burden of disease all over the world, including Hungary, as well. Diabetes is associated with an increased risk of numerous serious complications and comorbidities, although the risk is reduced if diabetes is well controlled. Diabetes imposes an increasing economic burden on each country's healthcare system especially due to the treatment of complications. Remote monitoring is not the future any more. Remote monitoring is a clinically proven solution that improves therapy outcomes and follow-up efficiency, while not compromising on safety. - Zoltán Melicher (Medtronic Hungaria)
13.05 - 13.59 Lunch, networking
14.00 - 14.40 Digital development in Hungary’s health care and health industry: building a digital ecosystem. The role of digitalization: improvement and protection of public health care. What are some of the problems in public health care that can be solved by digitalization? What has been solved already and what still needs to be done? - dr. Zoltán Birkner (NKFIH), Prof. Ildikó Horváth Ildikó, MD, PhD (Ministry of Human Capacities), Bálint Szabó (OKFŐ) - Moderátor: Hatem Lemia (Novartis Hungaria)
14.41 - 15.01 Cyber challenges in healthcare. - András Kabai és László Tóth (Deloitte Cyber Risk Services)
15.02 - 15.22 Telemedicine with utilization of BigData: COVID applications  - The unique insights accessed through BigData are already utilized by healthcare professionals in several disease areas to optimize therapy efficiency and drug adherence. Since the beginning of the pandemic, the potential of telemedicine and BigData are increasingly recognised by decision makers. In times when doctor-patient interactions are limited, the value of monitoring patients' health status remotely via smart devices has significantly increased. How do you utilise a telemedicine infrastructure to gain insights on coronavirus while keeping you patients safe? - Fruzsina Mezei (Omron Medistance)
15.23 - 15.43 Attila Ábrahám and Dániel Bálint (Egis Group) presentation
15.43 - 16.04 Video-based IoT technologies in healthcare - Attila Szűcs (Konica Minolta Hungary)
16.05 - 16.20 coffee break, networking
16.20 - 17.00 Digital, Channel & Tech Innovations In Times Of Change: Keep up with business-critical innovation and tech adoption trends. A Look Forward To 2021 & The Future Of Pharma: How has the face of pharma changed, is it embedded and what must we prepare for now? - Pharma Digital panel discussion - Selen Zeydanli Bisson (Merck), Mohamed Kamal (MSD, Zürich), Péter Vereczkei, MD (Pfizer), Moderator: Zoltán Novák, LL.M., PhD (TaylorWessing) (the conversation is in English, no rendering in other languages available)
17.00 - 17.45 University education in Health management - Round table with the professors - Prof. Balázs Benyó, PhD (BME), Prof. Miklós Kozlovszky, PhD (Óbudai Egyetem), Prof. Miklós Szócska, MD, PhD (SE), Prof. Péter Mihályi, PHD (Budapesti Corvinus Egyetem) - Moderator: Barnabás Málnay (Smartware.Tech & WS)

DHS Cafe (second floor)

11.00 - 17.00 Coffee, sandwich, networking, meeting room

Library (first floor)

11.05 - 11.44 A roundtable of Israeli digital health startups - Alon Kushnir (RedDress), Eyal Copitt (Cardiacsense), Jordan Rubinson (PulseNmore) - Moderator: Szabolcs Szolnoki (Science and Tech Diplomat of Hungary in Tel Aviv) (the presentation is in English, no rendering in other languages available)
11.45 - 12.21 Venture Capital in the health industry - Gergely Szűcs, PhD (Cashline Holding), Ernő Duda (Solvo) - Moderátor: Zita Albert (Cerha Hempel)
12.22 - 12.57 A roundtable of Hungarian digital health startups - Sándor Békási, MD (Fitpuli), Pal Heim (E-Group), Gábor Tóth, MD, PhD (Insimu) - Moderator: Olivér Koppány, Esq. (KNP LAW)
12.58 - 13.18 Venture capital investments in digital and offline medical devices - Gergely Szűcs, PhD (Cashline Holding)
13.18 - 14.10 Lunch, networking
14.10 - 14.55 Put Patients At The Heart Of Your Strategy: Easy-to-use platforms, action-driven strategies and customer-centric comms to boost patient engagement today - Pharma Digital panel discussion - Raffaella Bondi (Roche Hungary), Ákos Kókai-Nagy Ákos, MD (Biogen Hungary), Matt Zeller (Novartis Hungary) - Moderator: József Bulcsú Fenyvesi LL.M. (Oppenheim) (the conversation is in English, no rendering in other languages available)
14.56 - 15.12 Eszter Takácsi Nagy presentation (Andrékó Ferenczi Kinstellar Law Firm)
15.13 - 15.55 Remote patient follow-up - Monitoring, illness detection and prevention, Capitalize on wearable technologies to continuously monitor and detect illness through real time patient-generated data analysis. Collaborate with industry counterparts including academic medical researchers, patient organizations and pharma - to lead research and pioneer approaches to cancer treatment, diabetology and more. Assess remote and centralized monitoring tools to ensure data quality, site support and patient safety - Péter Becságh, PhD (Roche), Zoltán Melicher (Medtronic Hungary), Barnabás Szabó (77 Elektronika) - Moderator: Kornél Szabó (Sárhegyi Law Firm) 
15.55 - 16.10 Coffee break, networking
16.10 - 16.30 Benefits and challenges of remote patient follow up – a clinician’s view - Patients receiving a cardiac implantable electronic device –e .g pacemaker, defibrillator, event recorder – are an optimal target for remote follow up. The implanted device collects numerous valuable clinical data, which could be collected and monitored in a remote center. Remote monitoring in different patient groups has been effective to prevent hospitalisation and prolong life. Nevertheless, the wider use of the technology is slowed down by several challenges. - Gábor Duray, PhD, MD (zoom presentation) (Honvéd Hospital)
16.31 - 16.51 Health Security challenges in the 21st century - Health Security comes to mind most when we are suddenly threatened. Most of us don’t think that the safety of our health, the safety of our health protection and recovery systems, is threatened by global trends. In our presentation, we discuss health security and health security issues along a broader system of aspects. We present the health security aspects of health status, vaccinations and anti-vaccination activism, and data-driven health- and cybersecurity. - Tamás Palicz, MD (Semmelweis University, EMK)
16.52 - 17.12 Mit tanulhatunk a Koronavírus fertőzés elleni védekezés menedzseléséből? – Magyar helyzet illetve sikeres védekezést nyújtó országok stratégiája - Balázs Rékassy, MD

 

Workshop room (third floor)

11.05 - 13.05 Personalized healthcare: from vision to reality? - Cutting-edge technology alone will not provide personalised care to patients: the entire health system needs to undergo profound change. How could it happen? Six leading experts will discuss in an interdisciplinary round-table. - Szabolcs Békássy, MD, Zsolt Horváth, MD, Nóra Bittner, MD, Icó Tóth, Helga Feith, MD, Zsombor Zrubka, MD, PhD (SZEFA Magyar Személyre Szabott Egészségügy Fejlesztéséért Alapítvány / Roche Hungary.)
13.05 - 14.00 Lunch, networking
14.00 - 16.15 Novartis Digital Health Startup Competition - 6X8 mins Startup Pitch - Juries: Ernő Duda (Solvo), Dándor Varga-Tarr (Hiventures), Krisztián Kölkedi (NKFIH), Tamás Rákóczi (Novartis Hungary)
16.16 - 16.36 eHealth literacy: can one have too much of a good thing? - Digitalisation transforms radically health systems and patient-doctor relationships worldwide. People have access to health information without limits, while the paternalistic patient-physician relationship is gradually moving towards a partnership. However, contents available on the internet are frequently inadequate, and can be even harmful. Patients are becoming increasingly responsible for appraising the reliability of information from the internet. From a large national survey we gain overview about the eHealth literacy of the Hungarian general population, and we get insights about its relationship with people’s health status, lifestyle and patient-reported experiences with healthcare - Zsombor Zrubka, MD, PhD (HECON-Health Economics Research Center, Óbuda University)

 

 

 

 

general manager
Roche Hungary

Raffaella Claudia Bondi is an experienced pharmaceutical executive, with 20+ years in marketing and commercial roles, across several health-related businesses. She has been working at Roche for nearly 20 years. From diagnostics via the pharmaceutical industry to diabetes care, she gained experiences in many areas. She began her career in Italy, her home country, then held various positions at the affiliate in Denmark. In Switzerland, she became responsible for the entire European region, since November 2021 she is the General Manager of Roche Hungary. Passionate about partnering for better patient outcomes. She’s committed to co-creating with different stakeholders across the Hungarian healthcare ecosystem to ensure sustainability, access as well as boost innovation.

partner
Oppenheim Law Firm

Graduated from the Janus Pannonius University of Pécs in 1998 and pursued postgraduate studies in EU law at the University of Pécs. Obtained an LLM in International Economic Law at the University of Warwick in 2004. Attended the University of Oxford as a Chevening scholar and received a Magister Juris degree in 2006. Joined the Budapest office of Freshfields Bruckhaus Deringer in 2005. Associate of Oppenheim since 2007, partner at the firm since 2010. Head of the Corporate practice of Oppenheim since 2014.
Areas of specialization: Company Law, M&A, Capital MarketTransactions.
Sector experience: Capital markets, Chemicals & Pharma
Languages: Hungarian and English

Head of Public Affairs, Communications
Novartis Hungary

Lemia is an economist, graduated from Corvinus University of Budapest. After a short time spent in FMCG (Unilever) she immediately jumped into the world of pharmaceuticals where she’s been since 11 years now. After several roles in Communications and Public Affairs at Sanofi where she also spent a year in Sofia, Bulgaria; she joined MSD as Policy and Communications Lead where she was heavily involved in shaping public discussions around HPV vaccination and lung cancer. She is currently heading Public Affairs, Communications and Advocacy at Novartis Hungary. Lemia is passionate about public health issues, especially addressing health literacy & education and she’s a strong believer in the change civil society and patient advocates could make.

Innovation and Managing Director, Consultant, Owner
Szinapszis

Balázs has an MA in Economics and works for Szinapszis from the beginning as the professional leader of researches, also responsible for internal innovation and international relationships.  Balázs is a developer Szinapszis’ branded pharmaceutical solutions and research models. Main research areas: sales force effectiveness, pharmaceutical targeting, segmentation, KOL mapping, price sensitivity tests, MCM and digital transition in the pharma industry. Presenter on various Hungarian and International conferences, member end representative of Szinapszis in the European market research associations (ESOMAR, EphMRA).

Country Director
Biogen Hungary

Dr. Ákos Kókai-Nagy is currently the Country Director of the Hungarian Affiliate of Biogen

pharmaceutical company since 2017. Also, he is a Board member of the Association of Innovative Pharmaceutical Manufacturers (AIPM) since 2017, and the elected President of the organization since

2020. Dr. Ákos Kókai-Nagy graduated from Semmelweis University and, after several further courses, he graduated in 2012 with an EMBA qualification from Purdue University International Master of Management. During his career, he has held management positions at several pharmaceutical companies both in Hungary and abroad, including since 2012 he has been the Managing Director of Astellas Pharma in Denmark.

Health Policy Expert & Health Economist
Medistance

As a Health Policy Expert of the Hungarian National Public Health Centre since 2017, Fruzsi is strategically planning and implementing evidence-based developments in the field of primary care. She is currently working on improving care of six chronic disease groups that are leading causes of death in Hungary (e.g. hypertension, diabetes, oncological diseases etc.). She graduated as a Medical Anthropologist from Durham University in 2017 and received her MSc in Health Policy, Planning and Financing from ELTE in 2019. Stemming from her research background, she is an advocate of evidence-based policy making and aims to disseminate the idea of data collection and analytics to systematically address leading health issues. Working on national and international health care projects, primarily in the field of chronic care, she has first-hand experience in the barriers of implementing innovative digital solutions in the public health sphere. She works to overcome these barriers.

founder, Digital Health Summit

Rita Molnar earned her BA business communication degree in the Budapest College of Communication and Business in 2008. She completed her MBA master program at Budapest Metropolitan University in 2020 and she is now pursuing a Health Policy, Planning and Financing Master’s program at Budapest Corvinus University. The program is designed to provide you with a comprehensive understanding of the complexities of health care systems both at macro- and micro-levels within the context of technological development, an ageing population and patient expectations. She is well-prepared to work in health administration, government departments, research and consultancy agencies, universities, national health services, health care organizations and pharmaceutical and medical device industry. 

She started her career as a professional photojournalist from 1997 to 2002. Rita was just 21 when she started organizing events, and she founded her own company. Her first event was an amateur film festival in Eger in 1998. Ever since, she has been organizing 2 conferences per year, mainly in the medical, VC investing and banking fields. Between 2001-2005 Rita also worked as a movie producer. She was involved in co-producing a movie directed by the iconic Magyar movie-maker Miklós Jancsó. From 2006 to late 2007 Rita managed the event marketing team at Ringier Publishing, a Hungarian subsidiary of a Swiss-based leading publishing firm. In the summer of 2010 Rita founded Slimexpo with a venture capital involvement, and she organized with her own team a Slimexpo Festival with a diet, health and beauty theme at a premium event venue in Budapest Aréna in the spring of 2011. 

CEO, Oncompass Medicine

Istvan Petak, MD, Ph.D., is a physician and researcher. He has been developing technologies together with his team to find the best personalized, targeted therapy for cancer patients for over 20 years. His group was one of the pioneers of predictive molecular diagnostics. Their current development is a method to match the best, targeted therapy to each genetic alterations or combination of genetic changes in every cancer patient. This technique is being implemented into an artificial intelligence-based medical software system. This system and method received the award of the American  Society Clinical Oncology at their Breakthrough Oncology conference in Bangkok, and it also won the innovation prize of the GET IN THE RING V4, in 2019. Dr. Petak is the founder and CEO of Oncompass Medicine and regular lecturer of the Semmelweis University, Budapest, and the University of Illinois at Chicago.

Digital Lead
Novartis Hungaria

Tamás graduated as an economist and began his pharmaceutical career at Pfizer in 2009. During his more than 10 years there, he gained extensive experience in various departments (Finance, Business operation, Global Commercial operation), which was later utilized in the field of sales force excellence and he also played a decisive role in the company's digital development and implementation of new systems. After nearly 10 years on the support side, he had the opportunity to prove his abilities on the business side, for a year and a half in the Internal Medicine business unit he was responsible for promoting selected products through digital channels. He joined Novartis’s cardiovascular business unit as a product manager in 2020 and will continue his career in the Digital Lead position from 2021, where his main responsibilities will be the company’s digital development, mapping and implementing new, innovative opportunities and transforming the Omnichannel approach theory into practice.

deputy director of the Development Department, 77 Elektronika Kft

Barnabás is an engineer-economist with extensive experience in the medical device and diagnostics field.
He graduated from the Budapest University of Technology as a mechanical engineer in 2003 and did his postgraduate studies at the Budapest Corvinus University.
He started his career at the Budapest University of Technology, where he was involved in an international cardiovascular stent research and development project.
In 2007 he began to work at MED-EL GmbH. in Austria as a development project lead in the implantable neurostimulation field.
In 2011 he joined the Hungarian In Vitro Diagnostic company 77 Elektronika Kft. as diabetes topic manager and became soon deputy director of the Development Department. His responsibility is cross-functional device development of multiple product lines from idea to market release in international environment, including quality and regulatory aspects. His main area is Point of Care Testing and related digital health technologies.
Barnabás is a strategic planner with a high focus on medical product related innovation.
He is married and father of 3 children.